Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

gan Lindsay, C. R., Le Moulec, S., Billiot, F., Loriot, Y., Ngo-Camus, M., Vielh, P., Fizazi, K., Massard, C., Farace, F.
Cyhoeddwyd yn BMC Cancer (2016)

P13.14 Use of Foundation one CDx for molecular screening in patients with primary brain tumors: Gustave Roussy Experience

gan Baldini, C, Boulfoul, W, Lacroix, L, Rouleau, E, Scoazec, J, Varga, A, Hollebecque, A, Ribrag, V, Soria, J, Massard, C
Cyhoeddwyd yn Neuro Oncol (2019)

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

gan Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C
Cyhoeddwyd 2010

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

gan Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K
Cyhoeddwyd 2007

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

gan Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K
Cyhoeddwyd 2008

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

gan Farace, F, Massard, C, Vimond, N, Drusch, F, Jacques, N, Billiot, F, Laplanche, A, Chauchereau, A, Lacroix, L, Planchard, D, Le Moulec, S, André, F, Fizazi, K, Soria, J C, Vielh, P
Cyhoeddwyd 2011

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone

gan Massard, C., Mateo, J., Loriot, Y., Pezaro, C., Albiges, L., Mehra, N., Varga, A., Bianchini, D., Ryan, C. J., Petrylak, D. P., Attard, G., Shen, L., Fizazi, K., de Bono, J.
Cyhoeddwyd yn Ann Oncol (2017)

OS4.3 Feasibility and benefit of Molecular Profiling to Guide Enrollment of Patients with Recurrent Gliomas in Early Phase Trials

gan Baldini, C, Younan, N, Castanon Alvarez, E, Bahleda, R, Hollebecque, A, Dhermain, F, Ammari, S, Alentorn, A, Dumont, S, Frenel, J, Di Stefano, A, Bielle, F, Hoang-Xuan, K, Delattre, J, Soria, J, Sanson, M, Idbaih, A, Massard, C, Touat, M
Cyhoeddwyd yn Neuro Oncol (2019)